Intermediate alleles of huntington’s disease HTT gene in different populations worldwide: A systematic review

Genetics and Molecular Research

Volumn 16, Issue 2, 2017, Pages

  Apolinario T A ^a   Paiva, C L A ^a,b   Agostinho, L A ^a,c,d  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b Instituto Biomédico   (Brazil)

^c School of Physical Education   (Brazil)

^d Hospital de Câncer de Muriaé   (Brazil)

Author keywords

CAG repeats; Huntington s disease; Intermediate alleles; Prevalence

Indexed keywords

CLINICAL FEATURE; ETHNICITY; GENE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC STABILITY; HAPLOTYPE; HTT GENE; HUMAN; HUNTINGTON CHOREA; MOLECULAR DYNAMICS; PHENOTYPE; POPULATION DISTRIBUTION; PRODROMAL SYMPTOM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ALLELE; BRAZIL; GENETIC ASSOCIATION STUDY; GENETICS; HUNTINGTON DISEASE; METABOLISM; MUTATION; TRINUCLEOTIDE REPEAT;

HTT PROTEIN, HUMAN; HUNTINGTIN;

ALLELES; BRAZIL; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; HUNTINGTIN PROTEIN; HUNTINGTON DISEASE; MUTATION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 85017566880     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/gmr16029648     Document Type: Review

References (45)

1. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group (1998). ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. Am. J. Hum. Genet. 62: 1243-1247. http://dx.doi.org/10.1086/301846
2. Agostinho LdeA, Rocha CF, Medina-Acosta E, Barboza HN, et al. (2012). Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington’s disease. J. Hum. Genet. 57: 796-803. http://dx.doi.org/10.1038/jhg.2012.120
3. Agostinho LdeA, da Silva IdosS, Maia LA, Azevedo MdeA, et al. (2015). A Study of a Geographical Cluster of Huntington’s Disease in a Brazilian Town of Zona da Mata, Minas Gerais State. Eur. Neurol. 74: 62-68. http://dx.doi. org/10.1159/000434630
4. Alonso ME, Ochoa A, Boll MC, Sosa AL, et al. (2009). Clinical and genetic characteristics of Mexican Huntington’s disease patients. Mov. Disord. 24: 2012-2015. http://dx.doi.org/10.1002/mds.22737
5. Baine FK, Kay C, Ketelaar ME, Collins JA, et al. (2013). Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur. J. Hum. Genet. 21: 1120-1127. http://dx.doi.org/10.1038/ejhg.2013.2
6. Brocklebank D, Gayán J, Andresen JM, Roberts SA, et al.; International-Venezuela Collaborative Research Group (2009). Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B: 425-429. http://dx.doi.org/10.1002/ajmg.b.30826
7. Chong SS, Almqvist E, Telenius H, LaTray L, et al. (1997). Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Hum. Mol. Genet. 6: 301-309. http://dx.doi.org/10.1093/hmg/6.2.301
8. Costa MC, Magalhães P, Guimarães L, Maciel P, et al. (2006). The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation. J. Hum. Genet. 51: 189-195. http://dx.doi.org/10.1007/s10038-005-0343-8
9. Falush D, Almqvist EW, Brinkmann RR, Iwasa Y, et al. (2001). Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am. J. Hum. Genet. 68: 373-385. http://dx.doi.org/10.1086/318193
10. Feigin A (2013). Redefining the genetic risk for Huntington disease. Neurology 80: 2004-2005. http://dx.doi.org/10.1212/WNL.0b013e318294b49b
11. Goldberg YP, Kremer B, Andrew SE, Theilmann J, et al. (1993). Molecular analysis of new mutations for Huntington’s disease: intermediate alleles and sex of origin effects. Nat. Genet. 5: 174-179. http://dx.doi.org/10.1038/ng1093-174
12. Goldberg YP, McMurray CT, Zeisler J, Almqvist E, et al. (1995). Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum. Mol. Genet. 4: 1911-1918. http://dx.doi.org/10.1093/hmg/4.10.1911
13. Gusella JF, Wexler NS, Conneally PM, Naylor SL, et al. (1983). A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306: 234-238. http://dx.doi.org/10.1038/306234a0
14. Ha AD, Beck CA and Jankovic J (2012). Intermediate CAG Repeats in Huntington’s Disease: Analysis of COHORT. Tremor Other Hyperkinet. Mov. (N. Y.) 2: 2.
15. Hitt E. (2010). “Prevalence of Huntington’s Disease Underestimated.”
16. Kay C, Collins JA, Skotte NH, Southwell AL, et al. (2015). Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry. Mol. Ther. 23: 1759-1771. http://dx.doi.org/10.1038/mt.2015.128
17. Kelly TE, Allinson P, McGlennen RC, Baker J, et al. (1999). Expansion of a 27 CAG repeat allele into a symptomatic huntington disease-producing allele. Am. J. Med. Genet. 87: 91-92. http://dx.doi.org/10.1002/(SICI)1096-8628(19991105)87:1<91::AID-AJMG21>3.0.CO;2-J
18. Killoran A, Biglan KM, Jankovic J, Eberly S, et al. (2013). Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology 80: 2022-2027. http://dx.doi.org/10.1212/WNL.0b013e318294b304
19. Kremer B, Goldberg P, Andrew SE, Theilmann J, et al. (1994). A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med. 330: 1401-1406. http://dx.doi.org/10.1056/NEJM199405193302001
20. Lima e Silva TC, Serra HG, Bertuzzo CS and Lopes-Cendes I (2000). Molecular diagnosis of Huntington disease in Brazilian patients. Arq. Neuropsiquiatr. 58: 11-17. http://dx.doi.org/10.1590/S0004-282X2000000100002
21. Martin JB and Gusella JF (1986). Huntington’s disease. Pathogenesis and management. N. Engl. J. Med. 315: 1267-1276. http://dx.doi.org/10.1056/NEJM198611133152006
22. McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, et al. (2008). Huntington CAG repeat size does not modify onset age in familial Parkinson’s disease: the GenePD study. Mov. Disord. 23: 1596-1601. http://dx.doi.org/10.1002/mds.22186
23. Nahhas FA, Garbern J, Krajewski KM, Roa BB, et al. (2005). Juvenile onset Huntington disease resulting from a very large maternal expansion. Am. J. Med. Genet. A. 137A: 328-331. http://dx.doi.org/10.1002/ajmg.a.30891
24. Nance MA, Mathias-Hagen V, Breningstall G, Wick MJ, et al. (1999). Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington’s disease. Neurology 52: 392-394. http://dx.doi.org/10.1212/WNL.52.2.392
25. Paradisi I, Hernández A and Arias S (2008). Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation. J. Hum. Genet. 53: 127-135. http://dx.doi.org/10.1007/s10038-007-0227-1
26. Pearson CE, Nichol Edamura K and Cleary JD (2005). Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6: 729-742. http://dx.doi.org/10.1038/nrg1689
27. Pulkes T, Papsing C, Wattanapokayakit S and Mahasirimongkol S (2014). CAG-Expansion Haplotype Analysis in a Population with a Low Prevalence of Huntington’s Disease. J. Clin. Neurol. 10: 32-36. http://dx.doi.org/10.3988/jcn.2014.10.1.32
28. Raskin S, Allan N, Teive HA, Cardoso F, et al. (2000). Huntington disease: DNA analysis in Brazilian population. Arq. Neuropsiquiatr. 58: 977-985. http://dx.doi.org/10.1590/S0004-282X2000000600001
29. Rawlins M (2010). Huntington’s disease out of the closet? Lancet 376: 1372-1373. http://dx.doi.org/10.1016/S0140-6736(10)60974-9
30. Reilmann R, Leavitt BR and Ross CA (2014). Diagnostic criteria for Huntington’s disease based on natural history. Mov. Disord. 29: 1335-1341. http://dx.doi.org/10.1002/mds.26011
31. Semaka A, Creighton S, Warby S and Hayden MR (2006). Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin. Genet. 70: 283-294. http://dx.doi.org/10.1111/j.1399-0004.2006.00668.x
32. Semaka A, Collins JA and Hayden MR (2010). Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles). Am. J. Med. Genet. B. Neuropsychiatr. Genet. 153B: 314-320.
33. Semaka A, Kay C, Doty C, Collins JA, et al. (2013a). CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J. Med. Genet. 50: 696-703. http://dx.doi.org/10.1136/jmedgenet-2013-101796
34. Semaka A, Kay C, Doty CN, Collins JA, et al. (2013b). High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia’s general population. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B: 864-871. http://dx.doi.org/10.1002/ajmg.b.32193
35. Sequeiros J, Ramos EM, Cerqueira J, Costa MC, et al. (2010). Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin. Genet. 78: 381-387. http://dx.doi.org/10.1111/j.1399-0004.2010.01388.x
36. Spinney L (2010). Uncovering the true prevalence of Huntington’s disease. Lancet Neurol. 9: 760-761. http://dx.doi. org/10.1016/S1474-4422(10)70160-5
37. Squitieri F and Jankovic J (2012). Huntington’s disease: how intermediate are intermediate repeat lengths? Mov. Disord. 27: 1714-1717. http://dx.doi.org/10.1002/mds.25172
38. Squitieri F, Andrew SE, Goldberg YP, Kremer B, et al. (1994). DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum. Mol. Genet. 3: 2103-2114. http://dx.doi.org/10.1093/hmg/3.12.2103
39. The Huntington’s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72: 971-983. http://dx.doi.org/10.1016/0092-8674(93)90585-E
40. van Rij MC, de Koning Gans PA, Aalfs CM, Elting M, et al. (2014). Prenatal testing for Huntington’s disease in the Netherlands from 1998 to 2008. Clin. Genet. 85: 78-86. http://dx.doi.org/10.1111/cge.12090
41. Vázquez-Mojena Y, Laguna-Salvia L, Laffita-Mesa JM, González-Zaldívar Y, et al. (2013). Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testing. J. Neurol. Sci. 335: 101-104. http://dx.doi.org/10.1016/j.jns.2013.08.037
42. Warby SC, Montpetit A, Hayden AR, Carroll JB, et al. (2009). CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am. J. Hum. Genet. 84: 351-366. http://dx.doi.org/10.1016/j. ajhg.2009.02.003
43. Warby SC, Visscher H, Collins JA, Doty CN, et al. (2011). HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur. J. Hum. Genet. 19: 561-566. http://dx.doi.org/10.1038/ejhg.2010.229
44. Wexler NS, Lorimer J, Porter J, Gomez F, et al.; U.S.-Venezuela Collaborative Research Project (2004). Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc. Natl. Acad. Sci. USA 101: 3498-3503. http://dx.doi.org/10.1073/pnas.0308679101
45. Wheeler VC, Persichetti F, McNeil SM, Mysore JS, et al.; US-Venezuela Collaborative Research Group (2007). Factors associated with HD CAG repeat instability in Huntington disease. J. Med. Genet. 44: 695-701. http://dx.doi.org/10.1136/jmg.2007.050930